Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 136.10
-1.66 (-1.20%)
Aug 28, 2026, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 8.9 billion as of August 28, 2026. Its market cap has decreased by -54.89% in one year.
Market Cap
8.90B
Enterprise Value
8.93B
Revenue
2.35B
Ranking
n/a
PE Ratio
60.54
Stock Price
136.10
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 8.90B, an increase of 20,047.02%. That is a compound annual growth rate of 18.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 8.90B | -47.79% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.28B |
| Imricor Medical Systems | 695.63M |
| PolyNovo | 694.30M |
| EBR Systems | 222.24M |
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 156.25M |
| Lumos Diagnostics Holdings | 99.16M |